ArticleJournal of ovarian research2025

Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers.

Xiufen Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.